Dr. Marcus Muehlbauer, MD

Dr. Muehlbauer practices at HCA Florida North Florida Hospital - HOPD (6400 Newberry Road) in Gainesville, Florida.

Dr. Muehlbauer's NPI, 1093970121, was assigned on July 29, 2008. Dr. Muehlbauer graduated from University of Regensburg in 2001. Dr. Muehlbauer holds Florida license ME121643.

Dr. Muehlbauer's primary practice is HCA Florida North Florida Hospital - HOPD (6400 Newberry Road), at 6400 Newberry Road, Gainesville, FL 32605.

Dr. Muehlbauer's primary practice is HCA Florida North Florida Hospital - HOPD (6400 Newberry Road) in Gainesville, Florida. Dr. Muehlbauer is also affiliated with UF Health Shands Hospital. The medical group on file is Digestive Disease Associates of North Florida. Dmand AI also links Dr. Muehlbauer to 2 more hospitals, 1 group practice or clinic, 1 hospital outpatient department and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muehlbauer practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Muehlbauer's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Muehlbauer is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Muehlbauer's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastrointestinal bleeding among the conditions Dr. Muehlbauer treats.

CMS data shows 772 Medicare services from Dr. Muehlbauer across 13 procedure codes in 2024, for 482 Medicare patients. Medicare paid $77,651 for them.

CMS counts 482 Medicare patients who saw Dr. Muehlbauer in 2024. The largest group is 65 to 74, with 256 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Muehlbauer's median patient age at 64, with 58% women.

In 2024, Dr. Muehlbauer wrote 955 Medicare Part D claims for 226 patients. 78% of them were for generic drugs. CMS names the drug for 805 of them, across 26 drugs with 11 or more claims each, at $1,714,602 in total drug cost. In 2023, CMS named 668 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Muehlbauer for performance year 2024, reported individually. Dr. Muehlbauer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 126 procedures of colonoscopy by Dr. Muehlbauer, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Muehlbauer, published from 2022 to 2023.

Dmand AI links Dr. Muehlbauer to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Short Bowel Syndrome and Malabsorption Syndromes.

CMS Open Payments shows 61 general payments to Dr. Muehlbauer from 12 drug and device companies from 2016 to 2024. Speaker and faculty fees make up the largest share, 43% of the total. Abbvie Inc. paid the most, $14,015.

Dr. Muehlbauer graduated from University of Regensburg in 2001.

Dr. Muehlbauer is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.